Interaction
· Medical Videos
· Web Links
· Library
· Journals
· Search
Newsletters

Subscribe to our Mailing List

* indicates required
Login
Username
Password
Forgot Password!
Critical Care Research Academy

Program Description

The Critical Care Research Academy is a 12-months program that aims to increase the research knowledge and skills of critical care practitioners. The participants will learn how to critically evaluate the medical literature and how to develop, conduct and publish their own research. The program will involve didactic sessions, practice workshops, individual assignments, and group discussions which will be conducted through on-site and on-line meetings. In addition, each participant will be assigned to a mentor who will provide guidance and support when developing and conducting the research project.


Learning Objectives
By the end of the program, the participant will be able to:
  1. Develop a focused research question and conduct a systematic literature review.
  2. Critically evaluate the medical literature and interpret the findings of various types of clinical studies.
  3. Interpret the commonly used biostatistical terms.
  4. Describe the components of a research plan and complete an IRB protocol.
  5. Design and conduct a clinical research project at the participant’s institution.
  6. Analyze and interpret the findings a research project.
  7. Complete an abstract and a related poster that meets the standards and requirements for conference submission.
  8. Deliver an oral abstract presentation.
  9. Understand the requirements for writing a manuscript.
  10. Complete a research manuscript for publication.

Program Location
The course will be divided to two parts: a distance learning using Webex online platform and onsite workshops which will take place in Amman, Jordan.

Elegibility Criteria
Eligible candidates are health-care professionals practicing in the field of critical care who demonstrate motivation to develop their knowledge and skills in conducting clinical research. Applicants are required to submit a 1-2 page personal statement that describes their interest in research and describes a research idea that can be conducted in 4-6 months at their institution. In addition, a support letter from the applicant’s institution is required.

Registration Fees
The registration fees for participating in the Critical Care Research Academy are $1,750. The fees cover all educational elements of the program, course material, along with the meals during the onsite meetings.
Once the program starts, the fees are non-refundable.

Each participant is responsible for the travel and accommodation expenses to attend the two onsite meetings.


Attendance Requirement
Attendance of all onsite and online sessions is a major requirement for the completion of this program. If a student cannot attend a session, he/she is required to notify the program director as soon as possible to discuss the matter. Frequent absences may result in termination of the participant’s enrollment in the program.

Application

To apply for the course, please complete the application form and email to: researchacademy@mecriticalcare.net. The deadline for accepting applications is September 15, 2016.
No more than 10 participants will be accepted. A selection will be made based on the following criteria: .

  1. Personal motivation and research plans, as demonstrated in the applicant’s personal statement
  2. Institutional support to the participant.
  3. Critical care clinical experience

Program Outline and Schedule

You can download the preliminary schedule and program outline here


Academy Faculty

Ali Alazem, MD, FCCP

Lama Nazer, PharmD, BCPS
Program Director
Critical Care Medicine
King Hussain Cancer Center
Amman, Jordan
lama_nazer@hotmail.com

Dr. Nazer is a Clinical Pharmacy Specialist in Critical Care and the Head of the Pharmacy Research and Training program at King Hussein Cancer Center in Jordan. In addition, she is Assistant Clinical Professor at Rosalind Franklin University in North Chicago.
Dr. Nazer has developed and led several programs that aimed to increase research productivity among health care professionals. She has been extensively involved with teaching and mentoring in evidence based practice and research. Dr. Nazer’s areas of research include patient safety and critical care oncology and she has several publications in those fields. In addition, she has clinical and research interest in multidrug resistant pathogens, such as Acinetobacter baumannii, and in optimizing antimicrobial therapy in critically ill patients and has several publications in this area.

Ali Alazem, MD, FCCP

Ruth Kleinpell, PhD, RN, FAAN, FCCM

Dr. Kleinpell is the director of the Center for Clinical Research and Scholarship at Rush University Medical Center and a Professor at Rush University College of Nursing in Chicago.
Dr. Kleinpell has conducted research in several areas of focus such as outcomes of advanced practice nurses, quality of life of critically ill elders, and the use of telehealth to promote post-operative recovery. She has also received funding for several clinical projects such as a project targeting hypoglycemia prevention, funded by the American Association of Critical Care Nurses and a falls prevention initiative, funded by the American Organization of Nurse Executives. In her current role as director of the Center for Clinical Research and Scholarship, she oversees research and evidence based practice projects at Rush University Medical Center.

Ali Alazem, MD, FCCP
Ishaq Lat, PharmD, FCCM, FCCP, BCP

Dr. Lat is the Associate Director of the Clinical Pharmacy Services and Clinical Pharmacist Specialist in Critical Care at Rush University Medical Center in Chicago.
His clinical and research interests include shock syndromes, pharmacokinetics in critically ill patients, and sedation/analgesia/delirium in mechanically ventilated patients; he has written several research manuscripts, review articles, and book chapters on these topics. Dr. Lat also chairs the Critical Care Pharmacotherapy Trials Network, a group dedicated to collaborative research for critically ill patients
Kamal Mergani

Feras Hawari, MD, FCCP

Dr. Hawari is the Chief of Pulmonary and Critical Care, the Director of the Respiratory Unit and the Director of the Cancer Control Office at King Hussein Cancer Center in Jordan.
Dr. Hawari is active in research in the field of critical care oncology as well as tobacco control. He has conducted numerous studies to describe the clinical outcomes of critical care patients with cancer. In addition, he has received several grants to study the effect of tobacco and water pipes on the respiratory and cardiovascular functions of smokers.

Ali Alazem, MD, FCCP

Yahya Shehabi, MBBS, FANZCA, FJFICM, EMBA, GAICD

Dr Shehabi is a Professor at the School of Medicine at the University of New South Wales and School of Public Health and Preventive Medicine, Monash University Melbourne in Australia. He is the Medical Director of the Clinical Program of Acute Complex and Chronic Community Healthcare and the Director of Intensive Care Research at the Prince of Wales Hospitals in Sydney, Australia.
Dr Shehabi’s research interest focus on ICU sedation and the utility of biomarkers in critical illness. He is the Chief Investigator and architect of the SPICE Program, funded by a major grant from the NHMRC, focusing on changing sedation to improve patients’ centered outcome. He is also the Chief Investigator on a recently completed multicenter randomized controlled study on the utility of procalcitonin in critically ill patients

Facebook Twitter Pinterest Linkedin YouTube
Join MCCA - Board Members - MCCA Members - About MCCA